Localisation of PRP8, Brr2, Snu114 and U4/U6 proteins in the yeast tri-snRNP by electron microscopy

Department of Cellular Biochemistry, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, D-37077 Göttingen, Germany.
Nature Structural & Molecular Biology (Impact Factor: 13.31). 11/2008; 15(11):1206-12. DOI: 10.1038/nsmb.1506
Source: PubMed


The U4/U6-U5 tri-small nuclear ribonucleoprotein (snRNP) is a major, evolutionarily highly conserved spliceosome subunit. Unwinding of its U4/U6 snRNA duplex is a central event of spliceosome activation that requires several components of the U5 portion of the tri-snRNP, including the RNA helicase Brr2, Prp8 and the GTPase Snu114. Here we report the EM projection structure of the Saccharomyces cerevisiae tri-snRNP. It shows a modular organization comprising three extruding domains that contact one another in its central portion. We have visualized genetically tagged tri-snRNP proteins by EM and show here that U4/U6 snRNP forms a domain termed the arm. Conversely, a separate head domain adjacent to the arm harbors Brr2, whereas Prp8 and the GTPase Snu114 are located centrally. The head and arm adopt variable relative positions. This molecular organization and dynamics suggest possible scenarios for structural events during catalytic activation.

Download full-text


Available from: Patrizia Fabrizio, Feb 18, 2015
  • Source
    • "These characteristic domains can be easily identified, not only in class averages (Fig 1C) but also in the raw images (Fig 1D). Anti-TAP antibodies induce specific dimerisation of spliceosomes that contain a single TAP-tagged protein As described earlier (Häcker et al, 2008), proteins were located by immuno-labelling of the tri-snRNP particle, locating the antibody "
    [Show abstract] [Hide abstract]
    ABSTRACT: The spliceosome assembles on a pre-mRNA intron by binding of five snRNPs and numerous proteins, leading to the formation of the pre-catalytic B complex. While the general morphology of the B complex is known, the spatial arrangement of proteins and snRNP subunits within it remain to be elucidated. To shed light on the architecture of the yeast B complex, we immuno-labelled selected proteins and located them by negative-stain electron microscopy. The B complex exhibited a triangular shape with main body, head and neck domains. We located the U5 snRNP components Brr2 at the top and Prp8 and Snu114 in the centre of the main body. We found several U2 SF3a (Prp9 and Prp11) and SF3b (Hsh155 and Cus1) proteins in the head domain and two U4/U6 snRNP proteins (Prp3 and Lsm4) in the neck domain that connects the main body with the head. Thus, we could assign distinct domains of the B complex to the respective snRNPs and provide the first detailed picture of the subunit architecture and protein arrangements of the B complex.
    The EMBO Journal 11/2015; DOI:10.15252/embj.201592022 · 10.43 Impact Factor
  • Source
    • "Once again some of the topological features of the module are compatible with physical associations between these factors (e.g., PRP8 with PRP31 or U5-116K or PRP31 with C20ORF14). That knockdown of these late-acting factors, which coordinate the final steps of the splicing process (Bottner et al., 2005; Hä cker et al., 2008; Wahl et al., 2009 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pre-mRNA splicing relies on the poorly understood dynamic interplay between >150 protein components of the spliceosome. The steps at which splicing can be regulated remain largely unknown. We systematically analyzed the effect of knocking down the components of the splicing machinery on alternative splicing events relevant for cell proliferation and apoptosis and used this information to reconstruct a network of functional interactions. The network accurately captures known physical and functional associations and identifies new ones, revealing remarkable regulatory potential of core spliceosomal components, related to the order and duration of their recruitment during spliceosome assembly. In contrast with standard models of regulation at early steps of splice site recognition, factors involved in catalytic activation of the spliceosome display regulatory properties. The network also sheds light on the antagonism between hnRNP C and U2AF, and on targets of antitumor drugs, and can be widely used to identify mechanisms of splicing regulation
    Molecular Cell 01/2015; DOI:10.1016/j.molcel.2014.10.030 · 14.02 Impact Factor
  • Source
    • "Better known is the S. cerevisiae ortholog of U5-116 kD, the Snu114p. Häcker et al. could show that the Snu114p occupies a central position within the U4/U6-U5 tri-snRNP particle [14]. Fabrizio et al. concluded that the GTP-binding domain of the U5-116 kD protein plays an important role in either the splicing process itself or the recycling of spliceosomal snRNPs [13]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mutations in EFTUD2 were proven to cause a very distinct mandibulofacial dysostosis type Guion-Almeida (MFDGA, OMIM #610536). Recently, gross deletions and mutations in EFTUD2 were determined to cause syndromic esophageal atresia (EA), as well. We set forth to find further conditions caused by mutations in the EFTUD2 gene (OMIM *603892).Methods and resultsWe performed exome sequencing in two familial cases with clinical features overlapping with MFDGA and EA, but which were previously assumed to represent distinct entities, a syndrome with esophageal atresia, hypoplasia of zygomatic complex, microcephaly, cup-shaped ears, congenital heart defect, and intellectual disability in a mother and her two children [AJMG 143A(11):1135-1142, 2007] and a supposedly autosomal recessive oto-facial syndrome with midline malformations in two sisters [AJMG 132(4):398-401, 2005].While the analysis of our exome data was in progress, a recent publication made EFTUD2 mutations highly likely in these families. This hypothesis could be confirmed with exome as well as with Sanger sequencing. Also, in three further sporadic patients, clinically overlapping to these two families, de novo mutations within EFTUD2 were identified by Sanger sequencing. Our clinical and molecular workup of the patients discloses a broad phenotypic spectrum, and describes for the first time an instance of germline mosaicism for an EFTUD2 mutation. The clinical features of the eight patients described here further broaden the phenotypic spectrum caused by EFTUD2 mutations or deletions. We here show, that it not only includes mandibulofacial dysostosis type Guion-Almeida, which should be reclassified as an acrofacial dysostosis because of thumb anomalies (present in 12/35 or 34% of patients) and syndromic esophageal atresia [JMG 49(12). 737-746, 2012], but also the two new syndromes, namely oto-facial syndrome with midline malformations published by Megarbane et al. [AJMG 132(4): 398-401, 2005] and the syndrome published by Wieczorek et al. [AJMG 143A(11): 1135-1142, 2007] The finding of mild phenotypic features in the mother of one family that could have been overlooked and the possibility of germline mosaicism in apparently healthy parents in the other family should be taken into account when counseling such families.
    Orphanet Journal of Rare Diseases 07/2013; 8(1):110. DOI:10.1186/1750-1172-8-110 · 3.36 Impact Factor
Show more